Cannara Biotech (TSXV:LOVE) Other Long Term Assets : C$2.21 Mil (As of Aug. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Other Long Term Assets?

Cannara Biotech's other long-term assets for the quarter that ended in Aug. 2024 was C$2.21 Mil.

Cannara Biotech's quarterly other long-term assets declined from Feb. 2024 (C$0.26 Mil) to May. 2024 (C$0.26 Mil) but then increased from May. 2024 (C$0.26 Mil) to Aug. 2024 (C$2.21 Mil).

Cannara Biotech's annual other long-term assets increased from Aug. 2022 (C$0.30 Mil) to Aug. 2023 (C$0.31 Mil) and increased from Aug. 2023 (C$0.31 Mil) to Aug. 2024 (C$2.21 Mil).

Cannara Biotech Other Long Term Assets Historical Data

The historical data trend for Cannara Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Other Long Term Assets Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Other Long Term Assets

Get a 7-Day Free Trial

0.43

0.47

0.30

0.31

2.21

Cannara Biotech Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Other Long Term Assets	Get a 7-Day Free Trial															0.31	0.31	0.26	0.26	2.21

Cannara Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives

Nicholas Sosiak	Senior Officer
Olymbec Investments Inc.	10% Security Holder
Derek Elan Stern	Director
Donald John Olds	Director
Scott Carroll	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot	Director, Senior Officer
Brian Sherman	Senior Officer
Avi Krivorot	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer	Senior Officer
Jack M. Kay	Director
Donal Carroll	Director or Senior Officer of 10% Security Holder